Drug and Narcotic Control
"Drug and Narcotic Control" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.
| Descriptor ID |
D004335
|
| MeSH Number(s) |
I01.880.604.605.250 N03.706.615.402.250 N04.452.706.310
|
| Concept/Terms |
Pharmaceutical Policy- Pharmaceutical Policy
- Pharmaceutical Policies
- Policies, Pharmaceutical
- Policy, Pharmaceutical
- Pharmaceutic Policy
Narcotic Control- Narcotic Control
- Control, Narcotic
- Controls, Narcotic
- Narcotic Controls
Drug Control- Drug Control
- Control, Drug
- Controls, Drug
- Drug Controls
Drug Regulations- Drug Regulations
- Drug Regulation
- Regulation, Drug
- Regulations, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug and Narcotic Control".
Below are MeSH descriptors whose meaning is more specific than "Drug and Narcotic Control".
This graph shows the total number of publications written about "Drug and Narcotic Control" by people in this website by year, and whether "Drug and Narcotic Control" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug and Narcotic Control" by people in Profiles.
-
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysis. Harm Reduct J. 2025 12 31; 23(1):17.
-
Leftover Opioid Analgesics and Disposal Following Ambulatory Pediatric Surgeries in the Context of a Restrictive Opioid-Prescribing Policy. Anesth Analg. 2022 01 01; 134(1):133-140.
-
Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates. JAMA Netw Open. 2020 12 01; 3(12):e2027951.
-
Access to paediatric formulations for the treatment of childhood tuberculosis. Lancet Child Adolesc Health. 2020 12; 4(12):855-857.
-
Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences. J Pain Palliat Care Pharmacother. 2019 Mar - Jun; 33(1-2):22-31.
-
Corrective Statements from the Tobacco Industry: More Evidence for Why We Need Effective Tobacco Control. Ann Am Thorac Soc. 2018 02; 15(2):127-130.
-
Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products. Am J Health Syst Pharm. 2017 Dec 15; 74(24):2046-2053.
-
[Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences]. Rev Med Inst Mex Seguro Soc. 2016 Sep-Oct; 54(5):626-34.
-
Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad. Am J Ophthalmol. 2016 09; 169:xiv-xvi.
-
Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach. Res Social Adm Pharm. 2017 May - Jun; 13(3):503-512.